Laevolac (Lactulose, Liquid)

Lactulose is a synthetic sugar that is not absorbed in the small intestine. In the colon, bacteria break it down into short‑chain fatty acids, increasing osmotic pressure and pulling water into the bowel to soften stool. The resulting acidic environment also converts ammonia to ammonium, reducing its absorption into the bloodstream.

The dose of Laevolac is individualized by the prescribing clinician based on the patient’s age, condition, and response. Typical regimens start with a low dose that is gradually adjusted to achieve the desired effect, whether relieving constipation or managing hepatic encephalopathy. Exact dosing instructions should always come from a qualified healthcare professional.

Safety data for lactulose in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the use of Laevolac with their healthcare provider before starting therapy.

To order Laevolac, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details and any necessary import documentation.

Laevolac (lactulose) is an osmotic laxative that works by increasing colonic water content and lowering ammonia levels, which distinguishes it from stimulant laxatives such as bisacodyl. Compared with polyethylene glycol (PEG) solutions, lactulose also offers the benefit of ammonia reduction, making it the preferred choice for patients with hepatic encephalopathy.

Laevolac should be stored at ambient temperature, preferably below 25 °C. Keep the container tightly closed, protect it from moisture and direct sunlight, and retain it in the original packaging until use. Do not freeze the product, and discard any solution that appears discolored or contains particles.

Laevolac is taken orally as a liquid. The prescribed dose is measured with a calibrated spoon or syringe and can be mixed with a small amount of water, juice, or other non‑carbonated beverage if desired. It should be consumed as directed by the prescriber, typically once or twice daily, with or without food.

Serious risks, though uncommon, include electrolyte imbalances such as low potassium or sodium, severe abdominal pain that may signal intestinal obstruction, and allergic reactions presenting as rash, itching, or swelling. Patients should seek immediate medical attention if they experience any of these symptoms while using Laevolac.

Laevolac should be avoided in individuals with known hypersensitivity to lactulose, those with intestinal blockage, severe renal impairment, or active gastrointestinal disease that could be worsened by increased bowel motility. Pregnant or breastfeeding women should use it only after consulting a healthcare professional.